Literature DB >> 27184339

Investigating the Impact of a Genome-Wide Supported Bipolar Risk Variant of MAD1L1 on the Human Reward System.

Sarah Trost1, Esther K Diekhof1,2, Holger Mohr1,3, Henning Vieker1,4, Bernd Krämer1,5, Claudia Wolf1,6, Maria Keil1, Peter Dechent7, Elisabeth B Binder8, Oliver Gruber1,5.   

Abstract

Recent genome-wide association studies have identified MAD1L1 (mitotic arrest deficient-like 1) as a susceptibility gene for bipolar disorder and schizophrenia. The minor allele of the single-nucleotide polymorphism (SNP) rs11764590 in MAD1L1 was associated with bipolar disorder. Both diseases, bipolar disorder and schizophrenia, are linked to functional alterations in the reward system. We aimed at investigating possible effects of the MAD1L1 rs11764590 risk allele on reward systems functioning in healthy adults. A large homogenous sample of 224 young (aged 18-31 years) participants was genotyped and underwent functional magnetic resonance imaging (fMRI). All participants performed the 'Desire-Reason Dilemma' paradigm investigating the neural correlates that underlie reward processing and active reward dismissal in favor of a long-term goal. We found significant hypoactivations of the ventral tegmental area (VTA), the bilateral striatum and bilateral frontal and parietal cortices in response to conditioned reward stimuli in the risk allele carriers compared with major allele carriers. In the dilemma situation, functional connectivity between prefrontal brain regions and the ventral striatum was significantly diminished in the risk allele carriers. Healthy risk allele carriers showed a significant deficit of their bottom-up response to conditioned reward stimuli in the bilateral VTA and striatum. Furthermore, functional connectivity between the ventral striatum and prefrontal areas exerting top-down control on the mesolimbic reward system was reduced in this group. Similar alterations in reward processing and disturbances of prefrontal control mechanisms on mesolimbic brain circuits have also been reported in bipolar disorder and schizophrenia. Together, these findings suggest the existence of an intermediate phenotype associated with MAD1L1.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27184339      PMCID: PMC5026735          DOI: 10.1038/npp.2016.70

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  57 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  Personality traits and schizophrenia: evidence from a case-control study and meta-analysis.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Yuka Yasuda; Motoyuki Fukumoto; Hidenaga Yamamori; Masao Iwase; Hiroaki Kazui; Masatoshi Takeda
Journal:  Psychiatry Res       Date:  2012-03-05       Impact factor: 3.222

3.  Reward Processing in Unipolar and Bipolar Depression: A Functional MRI Study.

Authors:  Ronny Redlich; Katharina Dohm; Dominik Grotegerd; Nils Opel; Pienie Zwitserlood; Walter Heindel; Volker Arolt; Harald Kugel; Udo Dannlowski
Journal:  Neuropsychopharmacology       Date:  2015-04-16       Impact factor: 7.853

4.  Increased expression of mitotic arrest deficient-like 1 (MAD1L1) is associated with poor prognosis and insensitive to Taxol treatment in breast cancer.

Authors:  Qian Sun; Xianyu Zhang; Tong Liu; Xiaolong Liu; Jingshu Geng; Xiaohui He; Yang Liu; Da Pang
Journal:  Breast Cancer Res Treat       Date:  2013-07-17       Impact factor: 4.872

5.  Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).

Authors:  Carol A Tamminga; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Bradley Witte; David W Morris; Jeffrey Bishop; Gunvant K Thaker; John A Sweeney
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

6.  Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.

Authors: 
Journal:  Nat Genet       Date:  2011-09-18       Impact factor: 38.330

7.  Genome-wide association study identifies five new schizophrenia loci.

Authors: 
Journal:  Nat Genet       Date:  2011-09-18       Impact factor: 38.330

8.  Chapter 10: Mining genome-wide genetic markers.

Authors:  Xiang Zhang; Shunping Huang; Zhaojun Zhang; Wei Wang
Journal:  PLoS Comput Biol       Date:  2012-12-27       Impact factor: 4.475

Review 9.  Reinforcement learning and dopamine in schizophrenia: dimensions of symptoms or specific features of a disease group?

Authors:  Lorenz Deserno; Rebecca Boehme; Andreas Heinz; Florian Schlagenhauf
Journal:  Front Psychiatry       Date:  2013-12-23       Impact factor: 4.157

10.  Neural signal during immediate reward anticipation in schizophrenia: Relationship to real-world motivation and function.

Authors:  Karuna Subramaniam; Christine I Hooker; Bruno Biagianti; Melissa Fisher; Srikantan Nagarajan; Sophia Vinogradov
Journal:  Neuroimage Clin       Date:  2015-08-20       Impact factor: 4.881

View more
  10 in total

1.  Differences in Functional Connectivity Networks Related to the Midbrain Dopaminergic System-Related Area in Various Psychiatric Disorders.

Authors:  Yuko Nakamura; Naohiro Okada; Daisuke Koshiyama; Kouhei Kamiya; Osamu Abe; Akira Kunimatsu; Kazuo Okanoya; Kiyoto Kasai; Shinsuke Koike
Journal:  Schizophr Bull       Date:  2020-01-05       Impact factor: 9.306

2.  Replicated associations of FADS1, MAD1L1, and a rare variant at 10q26.13 with bipolar disorder in Chinese population.

Authors:  Lijuan Zhao; Hong Chang; Dong-Sheng Zhou; Jun Cai; Weixing Fan; Wei Tang; Wenxin Tang; Xingxing Li; Weiqing Liu; Fang Liu; Yuanfang He; Yan Bai; Yan Sun; Jiapei Dai; Lingyi Li; Xiao Xiao; Chen Zhang; Ming Li
Journal:  Transl Psychiatry       Date:  2018-12-07       Impact factor: 6.222

3.  A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons.

Authors:  Sergio Espeso-Gil; Tobias Halene; Jaroslav Bendl; Bibi Kassim; Gabriella Ben Hutta; Marina Iskhakova; Neda Shokrian; Pavan Auluck; Behnam Javidfar; Prashanth Rajarajan; Sandhya Chandrasekaran; Cyril J Peter; Alanna Cote; Rebecca Birnbaum; Will Liao; Tyler Borrman; Jennifer Wiseman; Aaron Bell; Michael J Bannon; Panagiotis Roussos; John F Crary; Zhiping Weng; Stefano Marenco; Barbara Lipska; Nadejda M Tsankova; Laura Huckins; Yan Jiang; Schahram Akbarian
Journal:  Genome Med       Date:  2020-02-19       Impact factor: 11.117

4.  Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs.

Authors:  H Le-Niculescu; K Roseberry; D F Levey; J Rogers; K Kosary; S Prabha; T Jones; S Judd; M A McCormick; A R Wessel; A Williams; P L Phalen; F Mamdani; A Sequeira; S M Kurian; A B Niculescu
Journal:  Mol Psychiatry       Date:  2019-03-12       Impact factor: 15.992

5.  Longitudinal epigenome-wide association studies of three male military cohorts reveal multiple CpG sites associated with post-traumatic stress disorder.

Authors:  Clara Snijders; Adam X Maihofer; Andrew Ratanatharathorn; Dewleen G Baker; Marco P Boks; Elbert Geuze; Sonia Jain; Ronald C Kessler; Ehsan Pishva; Victoria B Risbrough; Murray B Stein; Robert J Ursano; Eric Vermetten; Christiaan H Vinkers; Alicia K Smith; Monica Uddin; Bart P F Rutten; Caroline M Nievergelt
Journal:  Clin Epigenetics       Date:  2020-01-13       Impact factor: 6.551

6.  Identification of methylation changes associated with positive and negative growth deviance in Gambian infants using a targeted methyl sequencing approach of genomic DNA.

Authors:  Claire R Quilter; Kerry M Harvey; Julien Bauer; Benjamin M Skinner; Maria Gomez; Manu Shrivastava; Andrew M Doel; Saikou Drammeh; David B Dunger; Sophie E Moore; Ken K Ong; Andrew M Prentice; Robin M Bernstein; Carole A Sargent; Nabeel A Affara
Journal:  FASEB Bioadv       Date:  2021-02-05

7.  Identification of a Risk Locus at 7p22.3 for Schizophrenia and Bipolar Disorder in East Asian Populations.

Authors:  Wenqiang Li; Chu-Yi Zhang; Jiewei Liu; Fanglin Guan; Minglong Shao; Luwen Zhang; Qing Liu; Yongfeng Yang; Xi Su; Yan Zhang; Xiao Xiao; Xiong-Jian Luo; Ming Li; Luxian Lv
Journal:  Front Genet       Date:  2021-12-17       Impact factor: 4.599

8.  MAD1L1 and TSNARE gene polymorphisms are associated with schizophrenia susceptibility in the Han Chinese population.

Authors:  Xianglai Liu; Hailing Xie; Zejuan Fu; Qiankun Yao; Tianming Han; Dafei Zhan; Zhan Lin; Hong Zhu
Journal:  BMC Med Genomics       Date:  2021-09-04       Impact factor: 3.063

9.  DNA methylation as a potential mediator of the association between prenatal tobacco and alcohol exposure and child neurodevelopment in a South African birth cohort.

Authors:  Sarina Abrishamcar; Junyu Chen; Dakotah Feil; Anna Kilanowski; Nastassja Koen; Aneesa Vanker; Catherine J Wedderburn; Kirsten A Donald; Heather J Zar; Dan J Stein; Anke Hüls
Journal:  Transl Psychiatry       Date:  2022-09-30       Impact factor: 7.989

10.  Obsessive-compulsive disorder and attention-deficit/hyperactivity disorder: distinct associations with DNA methylation and genetic variation.

Authors:  Sarah J Goodman; Christie L Burton; Darci T Butcher; Michelle T Siu; Mathieu Lemire; Eric Chater-Diehl; Andrei L Turinsky; Michael Brudno; Noam Soreni; David Rosenberg; Kate D Fitzgerald; Gregory L Hanna; Evdokia Anagnostou; Paul D Arnold; Jennifer Crosbie; Russell Schachar; Rosanna Weksberg
Journal:  J Neurodev Disord       Date:  2020-08-16       Impact factor: 4.025

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.